packageDuvelisib

duvelisib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Duvelisib is a PI3K inhibitor used to treat chronic lymphocytic leukemia and follicular lymphoma. Its authorisation in the European Union has been withdrawn, but the drug has been approved and used elsewhere.

Summary written by glm-5.3-flash from Wikidata Q27077129 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:duvelisib
ATC codes:L01EM04
DrugBank:DB11952
PubChem CID:50905713
ChEBI:131169
Wikidata:Q27077129
formula:C22H17ClN6O
molar mass:416.869 g/mol (PubChem CID 50905713)
logP:4.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown